Sign in
4

Changes in Ownership

CNS Pharmaceuticals, Inc. Filed Acc 0001683168-23-002495

Chief Financial Officer bought 3,100 shares at $3.20 ($9,920)

From the SEC's structured data for this filing

Trades in this filing

Downs Christopher · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-04-17 Purchase : show line 1 in the form +3,100 $3.20 $9,920 9,251 D
Open-market purchases · 3,100 sh · avg $3.20 · $9,920
Loading xslF345X04/ownership.xml…